VNRX

Volitionrx Ltd

$0.33

-0.02 (-6.14%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 11.01.2026
$2.20
(+560.66%)
Strong Buy: 0
Buy: 4
Hold: 2
Sell: 0
Strong Sell: 0
Description:
VolitionRx Limited (VNRX) is a pioneering multinational company headquartered in Austin, Texas, specializing in epigenetics and the development of blood-based diagnostic tests to enhance cancer detection and diagnose various diseases globally. Leveraging its proprietary Nu.Q™ platform, VolitionRx is at the forefront of creating innovative, non-invasive diagnostic solutions designed to improve patient outcomes through early detection. With the expanding focus on precision medicine and the increasing demand for reliable diagnostic tools, the company is well-positioned to capture significant market opportunities, indicating robust growth potential in the evolving healthcare landscape.
Exchange:
NYSE MKT
Country:
USA
Sector:
HEALTHCARE
Industry:
MEDICAL DEVICES
Address:
1489 WEST WARM SPRINGS ROAD, HENDERSON, NV, UNITED STATES, 89014
Fiscal year end:
December
Market capitalization:
$40.9 Million
EBITDA:
-$21.7 Million
PERatio:
0.0
EPS:
-0.23
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.237

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
-94%
How much will you get:
$57
Prices dates:
31-12-2015: $4.50 and 31-12-2025: $0.26